Exosomes – tiny biological nanoparticles which transfer information between cells – offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.
Areas which could benefit include cancer treatment and regenerative medicine, say Dr Steven Conlan from Swansea University, Dr Mauro Ferrari of Houston Methodist Research Institute in Texas, and Dr Inês Mendes Pinto from the International Iberian Nanotechnology Laboratory in Portugal. Their commissioned paper, Exosomes as Reconfigurable Therapeutic Systems, is published today by Cell Press in Trends in Molecular Medicine.
Exosomes are particles produced by all cells in the body and are from 30-130 nanometres in size – a nanometre is one-billionth of a metre. They act as biological signalling systems, communicating between cells, carrying proteins, lipids, DNA and RNA. They drive biological processes, from modulating gene expression to transmitting information through breast milk.
Though discovered in 1983, the full potential of exosomes is only gradually being revealed. The researchers show that the nanoparticles’ possible medical benefits fall into three broad categories:
- Detecting disease – by acting as disease-specific biomarkers
- Activating immune responses to boost immunity
- Treating diseases – serving as the vehicle for drugs, for example bearing cancer therapies as their payload, to target tumours
One of the most useful properties of exosomes is that they are able to cross barriers such as the plasma membrane of cells, or the blood/brain barrier. This makes them well-suited to delivering therapeutic molecules in a very targeted way.
The potential benefits of exosomes can be seen in the wide range of research projects – cited in the paper – already either completed or under way, in areas such as:
- Improved testing for prostate cancer
- A small-cell lung cancer trial
- Stem cell-derived exosomes strengthening heart muscles
- Regeneration of muscle and tissue
The team caution that there is more to do before research into exosomes translates into new techniques and treatments. Side-effects need to be considered, and a standardised approach to isolating, characterising and storing exosomes will need to be developed.
Researchers will also need to ensure that the properties of exosomes do not end up causing harm: for example they can transfer drug resistance and pacify the immune system.
Nevertheless, the potential is very clear, with the team describing exosomes as “increasingly promising”.
Professor Steve Conlan of Swansea University Medical School, one of the authors of the paper, said:
“Our survey of research into exosomes shows clearly that they offer enormous potential as a basis for detecting and treating disease.
Further studies are necessary to turn this research into clinical outcomes, but researchers and funders should be very encouraged by our findings. Our own research in Swansea is investigating the use of exosomes and exosome-like synthetic nanoparticles in combatting ovarian and endometrial cancer.
Progress in this field depends on partnership. As the authorship of our own paper illustrates, researchers in different countries are increasingly working together in nanohealth. Swansea University has wider links with Houston and Portuguese based researchers in the field.
It’s also important to build partnerships outside academia, in particular with government and companies in this fast-growing sector.”
The Latest on: Exosomes
- Nasopharyngeal carcinoma treatment using exosomes derived from γδ-T cells synergized with radiotherapyon May 18, 2022 at 8:16 am
Exosomes are endosome-originated small extracellular vesicles that mediate intercellular communication. Compared with cell-based therapy, cell-free exosomes have advantages with higher safety ...
- Exosomes Market to Expand Robustly in 2022 | Lonza, Illumina, Qiagenon May 18, 2022 at 2:50 am
The latest study released on the Global Exosomes Market by AMA Research evaluates market size, trend, and forecast to 2027. The Exosomes market study covers significant research data and proofs to be ...
- Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinomaon May 17, 2022 at 10:00 pm
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergized with radiotherapy can control ...
- Codiak Presents New Preclinical Data at ASGCT 2022 on Exosome-Based Strategy to Enhance AAV Gene Therapyon May 17, 2022 at 4:02 am
Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced new ...
- Exosome Diagnostic and Therapeutic Market Dynamic Demand, Growth, Strategies and Forecast 2030on May 13, 2022 at 2:15 am
Furthermore, the high therapeutic potential of exosomes is yet another significant drivers for the global exosome diagnostic and therapeutic market. Another significant driving forces shaping the ...
- Exosomes Market: Key Insights Based on Product Type, Market Size, End-use and Regional Demand and Forecast: 2022-2031on May 13, 2022 at 12:06 am
Japan, Japan, Fri, 13 May 2022 07:06:08 / Comserve Inc. / -- The report predicts the global exosomes market to grow with a CAGR of 17.5% over the forecast period from 2022-2031. The report on the ...
- Exosomes Market Size Analysis & Growth Opportunities Forecast 2022-2031on April 28, 2022 at 3:37 am
The exosomes market is expected to register a CAGR of nearly 27.89% during the forecast period. Certain factors that are driving the market growth include increasing prevalence of cancer ...
- Cellular exosomes might improve delivery of anticancer drugs to tumours: Researchon April 25, 2022 at 9:01 am
In the study, researchers used exosomes produced by cells called adipose-derived mesenchymal stem cells (ADSCs) to deliver an RNA-based anti-cancer treatment (miR-138-5p) to bladder cancer tumours ...
- Cells' 'exosomes' may improve the delivery of anticancer drugs to tumorson April 20, 2022 at 12:36 am
In the study, researchers used exosomes produced by cells called adipose-derived mesenchymal stem cells (ADSCs) to deliver an RNA-based anti-cancer treatment (miR-138-5p) to bladder cancer tumors ...
via Google News and Bing News